Dr. Roy Bowden, DO

NPI: 1174594642
Total Payments
$16,021
2024 Payments
$1,983
Companies
56
Transactions
1,050
Medicare Patients
6,720
Medicare Billing
$606,106

Payment Breakdown by Category

Food & Beverage$15,896 (99.2%)
Education$125.74 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $15,896 1,046 99.2%
Education $125.74 4 0.8%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $2,431 237 $0 (2024)
ABBVIE INC. $1,760 85 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,639 83 $0 (2024)
Lilly USA, LLC $1,176 81 $0 (2024)
Amgen Inc. $853.87 55 $0 (2024)
PFIZER INC. $788.71 54 $0 (2024)
Novartis Pharmaceuticals Corporation $748.70 50 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $657.89 42 $0 (2024)
Merck Sharp & Dohme LLC $542.50 31 $0 (2024)
SANOFI-AVENTIS U.S. LLC $518.13 35 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,983 110 Novo Nordisk Inc ($410.31)
2023 $2,191 135 AbbVie Inc. ($564.52)
2022 $2,258 139 ABBVIE INC. ($486.25)
2021 $2,330 142 AbbVie Inc. ($341.50)
2020 $1,908 128 AstraZeneca Pharmaceuticals LP ($304.71)
2019 $1,466 105 Novo Nordisk Inc ($274.83)
2018 $1,905 132 Novo Nordisk Inc ($272.29)
2017 $1,982 159 Boehringer Ingelheim Pharmaceuticals, Inc. ($267.00)

All Payment Transactions

1,050 individual payment records from CMS Open Payments — Page 1 of 42

Date Company Product Nature Form Amount Type
12/19/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $19.66 General
Category: PAIN
12/16/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $19.17 General
Category: Diabetes
12/14/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $6.47 General
Category: Diabetes
12/13/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $8.72 General
Category: Diabetes
12/04/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $25.19 General
Category: Biological
12/03/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $17.16 General
Category: Oncology
11/20/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $21.18 General
Category: Endocrinology
11/13/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $21.07 General
Category: Cardio-renal
11/12/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $54.28 General
Category: Hematology
11/08/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $14.64 General
Category: Diabetes Care
11/07/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $14.45 General
Category: NEUROSCIENCE
11/04/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $18.33 General
Category: Diabetes
11/01/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $26.67 General
Category: Cardiology/Vascular Diseases
10/30/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.92 General
Category: NEUROSCIENCE
10/17/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.77 General
Category: PSYCHIATRY
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.10 General
Category: NEUROSCIENCE
10/16/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $16.47 General
Category: GASTROENTEROLOGY
10/13/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $20.59 General
Category: Diabetes
10/12/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.06 General
Category: Respiratory
10/09/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $29.57 General
Category: Otolaryngology (Ear, Nose, Throat)
10/03/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $18.90 General
Category: Cardiology/Vascular Diseases
10/02/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $20.24 General
Category: VACCINE
10/01/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $25.58 General
09/30/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $18.89 General
Category: Diabetes
09/27/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.23 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 1,549 2,907 $266,008 $145,344
2022 23 1,663 3,278 $305,767 $169,752
2021 28 1,715 3,204 $284,966 $151,047
2020 31 1,793 3,329 $304,221 $139,963
Total Patients
6,720
Total Services
12,718
Medicare Billing
$606,106
Procedure Codes
101

All Medicare Procedures & Services

101 procedure records from CMS Medicare Utilization — Page 3 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99496 Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge Office 2021 12 14 $5,250 $2,947 56.1%
90670 Pneumococcal vaccine for injection into muscle Office 2021 12 12 $3,300 $2,885 87.4%
99306 Initial nursing facility visit, typically 45 minutes per day Facility 2021 18 22 $4,950 $2,822 57.0%
G0444 Annual depression screening, 15 minutes Office 2021 140 140 $3,080 $2,405 78.1%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2021 13 13 $3,250 $2,031 62.5%
99335 Established patient assisted living visit, typically 25 minutes Office 2021 11 23 $2,990 $1,593 53.3%
99497 Advance care planning by the physician or other qualified health care professional, first 30 minutes Office 2021 20 20 $2,400 $1,547 64.4%
83036 Hemoglobin a1c level Office 2021 107 162 $4,860 $1,541 31.7%
90732 Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older Office 2021 11 11 $1,595 $1,373 86.1%
G0442 Annual alcohol misuse screening, 15 minutes Office 2021 71 71 $1,633 $1,220 74.7%
99308 Subsequent nursing facility visit, typically 15 minutes per day Facility 2021 12 24 $2,160 $1,163 53.8%
99439 Chronic care management services, each additional 20 minutes of clinical staff time per calendar month Office 2021 31 37 $1,480 $1,050 71.0%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Office 2021 11 11 $3,685 $769.25 20.9%
82044 Urine microalbumin (protein) analysis Office 2021 82 83 $1,411 $501.97 35.6%
77080 Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) Office 2021 12 12 $1,005 $413.52 41.1%
85610 Blood test, clotting time Office 2021 11 86 $2,150 $368.94 17.2%
99211 Established patient outpatient visit, minimal presenting problem Office 2021 13 22 $1,166 $199.44 17.1%
G0009 Administration of pneumococcal vaccine Office 2021 12 12 $312.00 $187.32 60.0%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2021 11 18 $360.00 $135.82 37.7%
81002 Urinalysis, manual test Office 2021 16 17 $153.00 $59.16 38.7%
99490 Chronic care management services at least 20 minutes per calendar month Office 2020 220 1,223 $67,305 $35,240 52.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 317 317 $61,815 $35,148 56.9%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 286 395 $44,240 $16,194 36.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 144 188 $30,080 $10,480 34.8%
99497 Advance care planning by the physician or other qualified health care professional Office 2020 73 73 $8,710 $5,892 67.6%

About Dr. Roy Bowden, DO

Dr. Roy Bowden, DO is a Internal Medicine healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174594642.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roy Bowden, DO has received a total of $16,021 in payments from pharmaceutical and medical device companies, with $1,983 received in 2024. These payments were reported across 1,050 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($15,896).

As a Medicare-enrolled provider, Bowden has provided services to 6,720 Medicare beneficiaries, totaling 12,718 services with total Medicare billing of $606,106. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Charleston, WV
  • Active Since 01/31/2006
  • Last Updated 09/04/2024
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1174594642

Products in Payments

  • Ozempic (Drug) $1,177
  • UBRELVY (Drug) $928.07
  • FARXIGA (Drug) $730.65
  • ENTRESTO (Drug) $600.05
  • QULIPTA (Drug) $533.52
  • JARDIANCE (Drug) $471.76
  • TRULICITY (Drug) $436.06
  • XIFAXAN (Drug) $375.34
  • BREZTRI (Drug) $347.75
  • Tresiba (Drug) $337.96
  • Aimovig (Biological) $302.49
  • Rybelsus (Drug) $297.32
  • Kerendia (Drug) $279.12
  • NURTEC ODT (Drug) $269.05
  • Vascepa (Drug) $258.08
  • VRAYLAR (Drug) $255.17
  • Prolia (Biological) $253.88
  • BELSOMRA (Drug) $250.38
  • XARELTO (Drug) $247.50
  • MOUNJARO (Drug) $239.68

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Charleston